Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation
Authors
Keywords
Recurrent hepatocellular carcinoma, Liver transplantation, Sorafenib, mTORi
Journal
LANGENBECKS ARCHIVES OF SURGERY
Volume 398, Issue 8, Pages 1123-1128
Publisher
Springer Nature
Online
2013-10-03
DOI
10.1007/s00423-013-1114-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Sorafenib in Advanced Hepatocellular Carcinoma Under Daily Practice Conditions
- (2014) M.W. Welker et al. JOURNAL OF CHEMOTHERAPY
- Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: A case-control study
- (2013) Carlo Sposito et al. JOURNAL OF HEPATOLOGY
- Meta-analysis: recurrence and survival following the use of sirolimus in liver transplantation for hepatocellular carcinoma
- (2012) K. V. Menon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation
- (2012) Arndt Weinmann et al. DIGESTIVE AND LIVER DISEASE
- Hepatocellular carcinoma
- (2012) Alejandro Forner et al. LANCET
- High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation
- (2012) Katharina Staufer et al. TRANSPLANT INTERNATIONAL
- Risk factors of survival after liver transplantation for HCC: a multivariate single-center analysis
- (2011) Katrin Hoffmann et al. CLINICAL TRANSPLANTATION
- Which matters most: Number of tumors, size of the largest tumor, or total tumor volume?
- (2011) Giacomo Germani et al. LIVER TRANSPLANTATION
- Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation
- (2010) D. H. Yoon et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principle
- (2010) Sherrie Bhoori et al. JOURNAL OF HEPATOLOGY
- Safety and Feasibility of Using Sorafenib in Recurrent Hepatocellular Carcinoma after Orthotopic Liver Transplantation
- (2010) Richard Kim et al. ONCOLOGY
- Recurrent Non-melanoma Skin Cancer: Remission of Field Cancerization after Conversion from Calcineurin Inhibitor- to Proliferation Signal Inhibitor-based Immunosuppression in a Cardiac Transplant Recipient
- (2010) J. Signorell et al. TRANSPLANTATION PROCEEDINGS
- Long-term survival after recurrent hepatocellular carcinoma in liver transplant patients: Clinical patterns and outcome variables
- (2009) A. Kornberg et al. EJSO
- Natural history and therapeutic management of recurrent hepatocellular carcinoma after liver transplantation
- (2009) A. Hollebecque et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma
- (2009) Christian Toso et al. HEPATOLOGY
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sirolimus Therapy in Liver Transplant Patients: An Initial Experience at a Single Center
- (2008) A. Nocera et al. TRANSPLANTATION PROCEEDINGS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search